Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients
出版年份 2020 全文链接
标题
Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients
作者
关键词
-
出版物
eLife
Volume 9, Issue -, Pages -
出版商
eLife Sciences Publications, Ltd
发表日期
2020-04-06
DOI
10.7554/elife.57278
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target
- (2020) Haibo Zhang et al. INTENSIVE CARE MEDICINE
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- COVID-19 and the cardiovascular system
- (2020) Ying-Ying Zheng et al. Nature Reviews Cardiology
- Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
- (2020) Daniel Wrapp et al. SCIENCE
- Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission
- (2020) Xintian Xu et al. Science China-Life Sciences
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Audio Interview: Practical Measures to Help Prevent Covid-19
- (2020) Eric J. Rubin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19
- (2020) Muthiah Vaduganathan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2)
- (2020) Ruiyun Li et al. SCIENCE
- Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
- (2020) Lei Fang et al. Lancet Respiratory Medicine
- Renin-Angiotensin System Blockers and the COVID-19 Pandemic
- (2020) A.H. Jan Danser et al. HYPERTENSION
- Ang-(1-7) treatment attenuates lipopolysaccharide-induced early pulmonary fibrosis
- (2019) Yongmei Cao et al. LABORATORY INVESTIGATION
- Targeting the renin–angiotensin system as novel therapeutic strategy for pulmonary diseases
- (2018) Wan Shun Daniel Tan et al. CURRENT OPINION IN PHARMACOLOGY
- The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases
- (2017) Xiao C. Li et al. PHARMACOLOGICAL RESEARCH
- Identification of Nafamostat as a Potent Inhibitor of Middle East Respiratory Syndrome Coronavirus S Protein-Mediated Membrane Fusion Using the Split-Protein-Based Cell-Cell Fusion Assay
- (2016) Mizuki Yamamoto et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activation of angiotensin-converting enzyme 2 (ACE2) attenuates allergic airway inflammation in rat asthma model
- (2016) Vaibhav Shrirang Dhawale et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Angiotensin-converting enzyme inhibitors and bacterial pneumonia in patients with Parkinson disease
- (2015) Han-Cheng Wang et al. MOVEMENT DISORDERS
- Angiotensin-converting enzyme 2 (ACE2) mediates influenza H7N9 virus-induced acute lung injury
- (2014) Penghui Yang et al. Scientific Reports
- Angiotensin-Converting Enzyme 2/Angiotensin-(1-7)/Mas Axis Protects against Lung Fibrosis by Inhibiting the MAPK/NF-κB Pathway
- (2013) Ying Meng et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Haemoconcentration, renal function, and post-discharge outcomes among patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial
- (2013) Stephen J. Greene et al. EUROPEAN JOURNAL OF HEART FAILURE
- TMPRSS2 and ADAM17 Cleave ACE2 Differentially and Only Proteolysis by TMPRSS2 Augments Entry Driven by the Severe Acute Respiratory Syndrome Coronavirus Spike Protein
- (2013) A. Heurich et al. JOURNAL OF VIROLOGY
- Post-Stroke Pneumonia Prevention by Angiotensin-Converting Enzyme Inhibitors: Results of a Meta-analysis of Five Studies in Asians
- (2012) Yukito Shinohara et al. ADVANCES IN THERAPY
- Angiotensin-converting enzyme inhibitor/angiotensin II receptor blockers and pneumonia risk among stroke patients
- (2012) Chia-Lin Liu et al. JOURNAL OF HYPERTENSION
- Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysis
- (2012) D. Caldeira et al. BMJ-British Medical Journal
- Local Renin-Angiotensin II Systems, Angiotensin-Converting Enzyme and its Homologue ACE2: Their Potential Role in the Pathogenesis of Chronic Obstructive Pulmonary Diseases, Pulmonary Hypertension and Acute Respiratory Distress Syndrome
- (2011) A. Kaparianos et al. CURRENT MEDICINAL CHEMISTRY
- Acute respiratory distress syndrome leads to reduced ratio of ACE/ACE2 activities and is prevented by angiotensin-(1-7) or an angiotensin II receptor antagonist
- (2011) Roelie M Wösten-van Asperen et al. JOURNAL OF PATHOLOGY
- The discovery of angiotensin-converting enzyme 2 and its role in acute lung injury in mice
- (2008) Yumiko Imai et al. EXPERIMENTAL PHYSIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started